Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

NCT02689726 ·Status: TERMINATED ·Phase: PHASE1

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

NCT06756269 ·Status: RECRUITING ·Phase: PHASE2

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

NCT06741150 ·Status: RECRUITING ·Phase: NA

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

NCT06465914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Treatment for HPV16+ ASC-US or LSIL

NCT03913117 ·Status: RECRUITING ·Phase: PHASE1

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

NCT06454175 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

NCT05584332 ·Status: TERMINATED ·Phase: PHASE3

A Pilot Study Comparing the Effectiveness of Campus Intervention to Increase HPV Vaccine Rate Among College Aged Men

NCT02508701 ·Status: TERMINATED ·Phase: NA

Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts

NCT06809777 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Gardasil Versus Cervarix in the Treatment of Warts

NCT05383625 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

NCT07175662 ·Status: RECRUITING ·Phase: PHASE2

Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

NCT03911076 ·Status: TERMINATED ·Phase: PHASE2

4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children

NCT01995721 ·Status: UNKNOWN ·Phase: PHASE3

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

NCT00115141 ·Status: COMPLETED ·Phase: PHASE2

Study With a Topical Gel to Treat Common Warts in Adults

NCT00117871 ·Status: COMPLETED ·Phase: PHASE2

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

NCT05625633 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive

NCT05905354 ·Status: UNKNOWN ·Phase: NA

Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts

NCT00674739 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)

NCT01796821 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts

NCT00735462 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.

NCT03206138 ·Status: UNKNOWN ·Phase: NA

Low Dose Cyclophosphamide Treats Genital Warts

NCT00999986 ·Status: COMPLETED ·Phase: PHASE3

Parent-son-provider Decision-making About HPV Vaccination

NCT01284374 ·Status: COMPLETED

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

NCT02750202 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts

NCT00499967 ·Status: COMPLETED ·Phase: PHASE1